Okla. Stat. tit. 36, § 36-6964: Formulary to identify drugs that offer greatest value

A. A health insurer's pharmacy and therapeutics committee (P&T

committee) shall establish a formulary, which shall be a list of

prescription drugs, both generic and brand name, used by

practitioners to identify drugs that offer the greatest overall

value.

B. A health insurer shall prohibit conflicts of interest for

members of the P&T committee.

1. A person may not serve on a P&T committee if the person is

currently employed or was employed within the preceding year by a

pharmaceutical manufacturer, developer, labeler, wholesaler or

distributor.

2. A health insurer shall require any member of the P&T

committee to disclose any compensation or funding from a

pharmaceutical manufacturer, developer, labeler, wholesaler or

distributor. Such P&T committee member shall be recused from voting

on any product manufactured or sold by such pharmaceutical

manufacturer, developer, labeler, wholesaler or distributor.